[Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
Costantino
S
S
Millozzi
F
F
Scarlata
S
S
D000803:Angiotensin I / Q000187:drug effects / Q000502:physiology; D000804:Angiotensin II / Q000037:antagonists & inhibitors* / Q000187:drug effects / Q000502:physiology; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D017706:Lisinopril / Q000494:pharmacology / Q000627:therapeutic use; D019808:Losartan / Q000494:pharmacology / Q000627:therapeutic use; D017257:Ramipril / Q000494:pharmacology / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011945:Receptors, Angiotensin / Q000187:drug effects / Q000502:physiology; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D012307:Risk Factors
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D000803:Angiotensin I; D017706:Lisinopril; D019808:Losartan; D017257:Ramipril